Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Cal/BD aerosol foam effectively treats scalp psoriasis, improving symptoms and patient satisfaction.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Vitamin E, alone or with yeast, helped reduce arsenic poisoning effects in young goats.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Sodium citrate causes less pain than acid citrate dextrose-A in PRP therapy.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.